Recently Viewed
Clear AllBidding Date
29-Nov-2024 to
03-Dec-2024
Issue Size
₹846.25 Cr
Price Band
₹420 to ₹441
Allotment date
04-Dec-2024
Listing date
06-Dec-2024
Lot size
34
No. of shares
1,91,89,330
Fresh issue/OFS
-- / ₹846.25 Cr
Established in 2005, the company operates as a diagnostic services provider with a well-established infrastructure spanning several regions of Eastern and North-Eastern India. The company offers integrated diagnostic services, including both pathology and radiology tests, as well as medical consultation. It operates under a "hub and spoke" model, where central laboratories (hub) manage specialized testing, and satellite locations (spokes) handle routine tests and sample collection. Its diagnostic services cover over 2,300 tests, spanning routine pathology tests (like biochemistry, hematology) to specialized tests (such as molecular pathology, MRI scans, and CT scans). As of June 30, 2024, the company has grown its operational network significantly, which includes its central reference laboratory, 8 satellite laboratories, 49 diagnostic centers, and 166 sample collection centers.
Category
Status
QIBs
1.7x
NIIs
1.4x
Retail
0.9x
Others
--
Total
1.3x
The issue size of Suraksha Diagnostic Ltd is ₹846.25 Cr.
Suraksha Diagnostic Ltd falls into Healthcare & Services industry.
The Suraksha Diagnostic Ltd IPO will be listed on both NSE and BSE.
The open and close dates for the Suraksha Diagnostic Ltd are 29-Nov-2024 & 03-Dec-2024.
The price band for the Suraksha Diagnostic Ltd ipo is ₹420 to ₹441
The listing date of Suraksha Diagnostic Ltd IPO is 06-Dec-2024.
The purpose of this IPO is to enable the existing shareholders to sell their stake.
Suraksha Diagnostic Ltd total subscription ratio is 1.3X.
Key financial of the Suraksha Diagnostic Ltd are:
Suraksha Diagnostic Ltd | FY-24 | FY-23 | FY-22 |
---|---|---|---|
Revenue (₹ Cr) | 218.7 | 190.1 | 223.2 |
EBIT (₹ Cr) | 37.5 | 12.3 | 34.2 |
Proft after Tax (₹ Cr) | 23.1 | 6.1 | 20.8 |
Debt (₹ Cr) | 8.7 | 14 | 19 |
Net Worth (₹ Cr) | 179.1 | 155.5 | 145.8 |
RoE (%) | 12.9 | 3.92 | 14.27 |